{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:21:29Z","timestamp":1791116489970,"version":"4.1.0"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,6,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>One of the requirements for efficient vaccination against infection is to achieve the best combination of an adequate adjuvant with the antigenic information to deliver. Although plasmid DNA is a promising tool bearing the unique potential to activate humoral and cellular immunity, an actual challenge is to increase plasmid immunogenicity in human vaccination protocols in which efficacy has proven rather limited. Previous work showed that the bacterial DNA backbone of the plasmid has potent adjuvant properties because it contains CpG motifs that are particular activating nucleotidic sequences. Among TLRs, which are key sensors of microbial products, TLR9 can detect CpG motifs and confer activation of APCs, such as dendritic cells. However, whether the immunogenic properties of plasmid DNA involve TLR9 signaling has not been clearly established. In the current study, we demonstrate that TLR9 determines the effectiveness of vaccination against lethal lymphocytic choriomeningitis virus infection using plasmid DNA in a prime, but not prime-boost, vaccination regimen. Furthermore, we provide evidence that the presence of TLR9 in dendritic cells is necessary for effective and functional priming of virus-specific CD8+ T cells upon plasmid exposure in vitro or single-dose vaccination in vivo. Therefore, at single or low vaccine doses that are often used in human-vaccination protocols, CpG\/TLR9 interactions participate in the immunogenicity of plasmid DNA. These results suggest that the TLR9 signaling pathway is involved in the efficacy of plasmid vaccination; therefore, it should remain a focus in the development or amelioration of vaccines to treat infections in humans.<\/jats:p>","DOI":"10.4049\/jimmunol.0803935","type":"journal-article","created":{"date-parts":[[2010,5,7]],"date-time":"2010-05-07T22:34:55Z","timestamp":1273271695000},"page":"7100-7107","source":"Crossref","is-referenced-by-count":37,"title":["Essential Role for TLR9 in Prime but Not Prime-Boost Plasmid DNA Vaccination To Activate Dendritic Cells and Protect from Lethal Viral Infection"],"prefix":"10.1093","volume":"184","author":[{"given":"Diane","family":"Rottembourg","sequence":"first","affiliation":[{"name":"La Jolla Institute for Allergy and Immunology , La Jolla, CA 92037"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe M","family":"Filippi","sequence":"additional","affiliation":[{"name":"La Jolla Institute for Allergy and Immunology , La Jolla, CA 92037"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Bresson","sequence":"additional","affiliation":[{"name":"La Jolla Institute for Allergy and Immunology , La Jolla, CA 92037"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Ehrhardt","sequence":"additional","affiliation":[{"name":"La Jolla Institute for Allergy and Immunology , La Jolla, CA 92037"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A","family":"Estes","sequence":"additional","affiliation":[{"name":"La Jolla Institute for Allergy and Immunology , La Jolla, CA 92037"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine E","family":"Oldham","sequence":"additional","affiliation":[{"name":"La Jolla Institute for Allergy and Immunology , La Jolla, CA 92037"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias G","family":"von Herrath","sequence":"additional","affiliation":[{"name":"La Jolla Institute for Allergy and Immunology , La Jolla, CA 92037"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2010,6,15]]},"reference":[{"key":"2026012806331228300_r1","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1146\/annurev.immunol.15.1.617","article-title":"DNA vaccines.","volume":"15","author":"Donnelly","year":"1997","journal-title":"Annu. Rev. Immunol."},{"key":"2026012806331228300_r2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.0105-2896.2004.00146.x","article-title":"DNA vaccines and adjuvants.","volume":"199","author":"Stevenson","year":"2004","journal-title":"Immunol. Rev."},{"key":"2026012806331228300_r3","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1126\/science.1690918","article-title":"Direct gene transfer into mouse muscle in vivo.","volume":"247","author":"Wolff","year":"1990","journal-title":"Science"},{"key":"2026012806331228300_r4","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1084\/jem.184.4.1555","article-title":"Gene vaccination with naked plasmid DNA: mechanism of CTL priming.","volume":"184","author":"Corr","year":"1996","journal-title":"J. Exp. Med."},{"key":"2026012806331228300_r5","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/BF03401683","article-title":"Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes.","volume":"3","author":"Fu","year":"1997","journal-title":"Mol. Med."},{"key":"2026012806331228300_r6","doi-asserted-by":"crossref","first-page":"8578","DOI":"10.1073\/pnas.93.16.8578","article-title":"Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells.","volume":"93","author":"Doe","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2026012806331228300_r7","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.4049\/jimmunol.165.5.2850","article-title":"Distribution of DNA vaccines determines their immunogenicity after intramuscular injection in mice.","volume":"165","author":"Dupuis","year":"2000","journal-title":"J. Immunol."},{"key":"2026012806331228300_r8","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1172\/JCI200422608","article-title":"Recruitment and expansion of dendritic cells in vivo potentiate the immunogenicity of plasmid DNA vaccines.","volume":"114","author":"Sumida","year":"2004","journal-title":"J. Clin. Invest."},{"key":"2026012806331228300_r9","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1084\/jem.189.1.169","article-title":"DNA vaccination: transfection and activation of dendritic cells as key events for immunity.","volume":"189","author":"Akbari","year":"1999","journal-title":"J. Exp. Med."},{"key":"2026012806331228300_r10","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1172\/JCI0215962","article-title":"Exploiting dendritic cells to improve vaccine efficacy.","volume":"109","author":"Steinman","year":"2002","journal-title":"J. Clin. Invest."},{"key":"2026012806331228300_r11","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.coi.2004.02.005","article-title":"The role of programming in memory T-cell development.","volume":"16","author":"Masopust","year":"2004","journal-title":"Curr. Opin. Immunol."},{"key":"2026012806331228300_r12","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/S0140-6736(97)09440-3","article-title":"Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients.","volume":"351","author":"Calarota","year":"1998","journal-title":"Lancet"},{"key":"2026012806331228300_r13","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1086\/515613","article-title":"First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response.","volume":"178","author":"MacGregor","year":"1998","journal-title":"J. Infect. Dis."},{"key":"2026012806331228300_r14","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1126\/science.282.5388.476","article-title":"Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine.","volume":"282","author":"Wang","year":"1998","journal-title":"Science"},{"key":"2026012806331228300_r15","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/35047123","article-title":"A Toll-like receptor recognizes bacterial DNA.","volume":"408","author":"Hemmi","year":"2000","journal-title":"Nature"},{"key":"2026012806331228300_r16","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1126\/science.273.5273.352","article-title":"Immunostimulatory DNA sequences necessary for effective intradermal gene immunization.","volume":"273","author":"Sato","year":"1996","journal-title":"Science"},{"key":"2026012806331228300_r17","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1146\/annurev.immunol.20.100301.064842","article-title":"CpG motifs in bacterial DNA and their immune effects.","volume":"20","author":"Krieg","year":"2002","journal-title":"Annu. Rev. Immunol."},{"key":"2026012806331228300_r18","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.0105-2896.2004.00148.x","article-title":"Use of CpG oligodeoxynucleotides as immune adjuvants.","volume":"199","author":"Klinman","year":"2004","journal-title":"Immunol. Rev."},{"key":"2026012806331228300_r19","first-page":"143","article-title":"Designing immune responses with genetic immunization and immunostimulatory DNA sequences.","volume":"35","author":"Thalhamer","year":"2001","journal-title":"Endocr. Regul."},{"key":"2026012806331228300_r20","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.4049\/jimmunol.177.4.2036-a","article-title":"Comment on \u201cCutting edge: anti-CD25 monoclonal antibody injection results in the functional inactivation, not depletion, of CD4+CD25+ T regulatory cells\u201d.","volume":"177","author":"Zelenay","year":"2006","journal-title":"J. Immunol."},{"key":"2026012806331228300_r21","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.4049\/jimmunol.158.8.3635","article-title":"Contribution of CpG motifs to the immunogenicity of DNA vaccines.","volume":"158","author":"Klinman","year":"1997","journal-title":"J. Immunol."},{"key":"2026012806331228300_r22","doi-asserted-by":"crossref","first-page":"6341","DOI":"10.1016\/j.vaccine.2007.06.016","article-title":"Priming of CD8+ T-cell responses after DNA immunization is impaired in TLR9- and MyD88-deficient mice.","volume":"25","author":"Pavlenko","year":"2007","journal-title":"Vaccine"},{"key":"2026012806331228300_r23","doi-asserted-by":"crossref","first-page":"5908","DOI":"10.4049\/jimmunol.171.11.5908","article-title":"Vaccination with plasmid DNA activates dendritic cells via Toll-like receptor 9 (TLR9) but functions in TLR9-deficient mice.","volume":"171","author":"Spies","year":"2003","journal-title":"J. Immunol."},{"key":"2026012806331228300_r24","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.vaccine.2004.09.001","article-title":"TLR9 pathway is involved in adjuvant effects of plasmid DNA-based vaccines.","volume":"23","author":"Tudor","year":"2005","journal-title":"Vaccine"},{"key":"2026012806331228300_r25","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1365-2567.2004.01938.x","article-title":"TLR9-\/- and TLR9+\/+ mice display similar immune responses to a DNA vaccine.","volume":"113","author":"Babiuk","year":"2004","journal-title":"Immunology"},{"key":"2026012806331228300_r26","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/jgm.709","article-title":"Direct injection of plasmid DNA into the skin induces dermatitis by activation of monocytes through toll-like receptor 9.","volume":"7","author":"Sawamura","year":"2005","journal-title":"J. Gene Med."},{"key":"2026012806331228300_r27","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1002\/eji.1830210930","article-title":"Involvement of both T cell receptor V alpha and V beta variable region domains and alpha chain junctional region in viral antigen recognition.","volume":"21","author":"Br\u00e4ndle","year":"1991","journal-title":"Eur. J. Immunol."},{"key":"2026012806331228300_r28","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1128\/jvi.69.4.2684-2688.1995","article-title":"DNA immunization confers protection against lethal lymphocytic choriomeningitis virus infection.","volume":"69","author":"Yokoyama","year":"1995","journal-title":"J. Virol."},{"key":"2026012806331228300_r29","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S1074-7613(00)80540-3","article-title":"Coordinate regulation of complex T cell populations responding to bacterial infection.","volume":"8","author":"Busch","year":"1998","journal-title":"Immunity"},{"key":"2026012806331228300_r30","doi-asserted-by":"crossref","first-page":"8286","DOI":"10.1128\/JVI.74.18.8286-8291.2000","article-title":"Direct ex vivo kinetic and phenotypic analyses of CD8(+) T-cell responses induced by DNA immunization.","volume":"74","author":"Hassett","year":"2000","journal-title":"J. Virol."},{"key":"2026012806331228300_r31","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1128\/JVI.72.5.3812-3818.1998","article-title":"Dendritic cells efficiently induce protective antiviral immunity.","volume":"72","author":"Ludewig","year":"1998","journal-title":"J. Virol."},{"key":"2026012806331228300_r32","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.4049\/jimmunol.174.4.1851","article-title":"Rapid activation of spleen dendritic cell subsets following lymphocytic choriomeningitis virus infection of mice: analysis of the involvement of type 1 IFN.","volume":"174","author":"Montoya","year":"2005","journal-title":"J. Immunol."},{"key":"2026012806331228300_r33","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.4049\/jimmunol.174.7.3920","article-title":"Priming of CTLs by lymphocytic choriomeningitis virus depends on dendritic cells.","volume":"174","author":"Probst","year":"2005","journal-title":"J. Immunol."},{"key":"2026012806331228300_r34","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.4049\/jimmunol.170.8.4102","article-title":"A subset of Toll-like receptor ligands induces cross-presentation by bone marrow-derived dendritic cells.","volume":"170","author":"Datta","year":"2003","journal-title":"J. Immunol."},{"key":"2026012806331228300_r35","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.0022-202X.2004.23208.x","article-title":"CpG motifs are efficient adjuvants for DNA cancer vaccines.","volume":"123","author":"Schneeberger","year":"2004","journal-title":"J. Invest. Dermatol."},{"key":"2026012806331228300_r36","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/nm0703-831","article-title":"CpG motifs: the active ingredient in bacterial extracts?","volume":"9","author":"Krieg","year":"2003","journal-title":"Nat. Med."},{"key":"2026012806331228300_r37","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/sj.gt.3302240","article-title":"IL-18 gene therapy develops Th1-type immune responses in Leishmania major-infected BALB\/c mice: is the effect mediated by the CpG signaling TLR9?","volume":"11","author":"Li","year":"2004","journal-title":"Gene Ther."},{"key":"2026012806331228300_r38","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.2337\/diabetes.49.12.1998","article-title":"Suppression and acceleration of autoimmune diabetes by neutralization of endogenous interleukin-12 in NOD mice.","volume":"49","author":"Fujihira","year":"2000","journal-title":"Diabetes"},{"key":"2026012806331228300_r39","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/S0264-410X(02)00676-X","article-title":"The role of lipopolysaccharide in T-cell responses following DNA vaccination.","volume":"21","author":"Hawkins","year":"2003","journal-title":"Vaccine"},{"key":"2026012806331228300_r40","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4049\/jimmunol.154.1.97","article-title":"CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL.","volume":"154","author":"Lanier","year":"1995","journal-title":"J. Immunol."},{"key":"2026012806331228300_r41","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0092-8674(95)90349-6","article-title":"B7-1 and B7-2 costimulatory molecules activate differentially the Th1\/Th2 developmental pathways: application to autoimmune disease therapy.","volume":"80","author":"Kuchroo","year":"1995","journal-title":"Cell"},{"key":"2026012806331228300_r42","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nature06537","article-title":"TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines.","volume":"451","author":"Ishii","year":"2008","journal-title":"Nature"},{"key":"2026012806331228300_r43","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1089\/dna.2006.25.253","article-title":"TLR9-independent activation of B lymphocytes by bacterial DNA.","volume":"25","author":"Cortez-Gonzalez","year":"2006","journal-title":"DNA Cell Biol."}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/184\/12\/7100\/62712128\/ji_0803935.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/184\/12\/7100\/62712128\/ji_0803935.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T11:37:12Z","timestamp":1769600232000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/184\/12\/7100\/8007279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":43,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2010,6,15]]},"published-print":{"date-parts":[[2010,6,15]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.0803935","relation":{},"ISSN":["1550-6606","0022-1767"],"issn-type":[{"value":"1550-6606","type":"electronic"},{"value":"0022-1767","type":"print"}],"subject":[],"published-other":{"date-parts":[[2010,6]]},"published":{"date-parts":[[2010,6]]}}}